# MiMedx (MDXG) Stock Price, News & Analysis
Canonical URL: https://biopharmsignal.com/company/MDXG
## Company Profile
- Ticker: MDXG
- Exchange: NASDAQ
- Sector: Biopharma
- Location: United States
- Tags: Biologics
## Stock Data
- Close: 4.16 USD
- Market cap: 531736259.66999996 USD
- Last updated: 2026-08-05
## Business Overview
### Placental Tissue Products
MIMEDX develops and commercializes placental-tissue products for wound care, burns and surgery. Its processing and product portfolio are designed to provide extracellular-matrix and biologic materials that support healing and tissue repair.
### Wound-Care Portfolio
The company has more than a decade of experience serving chronic and difficult-to-heal wounds. Products are used by clinicians across outpatient and other care settings where advanced wound coverage and healing support are required.
### Surgical and Pipeline Products
The surgical portfolio includes AMNIOFIX, AMNIOEFFECT and particulate products. MIMEDX is also investing in newer products such as CHORIOFIX and in a randomized controlled study of EPIEFFECT.
## Why The Stock Is Moving

As of Aug 5, 2026, MDXG closed down 2.58% at $4.16. No new same-company headline was identified in the current news window.

## Future Catalysts

- MiMedx's catalysts are wound-care growth and placental-biologic demand, with the stock moving on commercial execution rather than headline science. The company improves when the commercial base keeps compounding.

## Recent News
- 2026-07-29 20:07 EST — [MIMEDX Announces Second Quarter 2026 Operating & Financial Results](https://biopharmsignal.com/news/MDXG/mimedx-announces-second-quarter-2026-operating-financial-results-2c1638cf) — Source: MiMedx
- 2026-07-29 20:01 EST — [MIMEDX to Acquire Sanara MedTech](https://biopharmsignal.com/news/MDXG/mimedx-to-acquire-sanara-medtech-f0a3d419) — Source: MiMedx
- 2026-07-20 12:00 EST — [MIMEDX to Host Second Quarter 2026 Operating and Financial Results Conference Call on July 29](https://biopharmsignal.com/news/MDXG/mimedx-to-host-second-quarter-2026-operating-and-financial-results-conference-ca-b62fe7a7) — Source: MiMedx
- 2026-05-21 12:45 EST — [MIMEDX to Participate in Craig-Hallum 23rd Annual Institutional Investor Conference](https://biopharmsignal.com/news/MDXG/mimedx-to-participate-in-craig-hallum-23rd-annual-institutional-investor-conference) — Source: MiMedx
- 2026-05-08 12:00 EST — [MIMEDX Announces Launch of G4Derm® Plus](https://biopharmsignal.com/news/MDXG/mimedx-announces-launch-of-g4dermr-plus) — Source: MiMedx